Exact Mass: 724.3825

Alliospiroside C

C38H60O13 (724.4034)

Constituent of Allium cepa (onion). Alliospiroside C is found in garden onion and onion-family vegetables. Alliospiroside C is found in garden onion. Alliospiroside C is a constituent of Allium cepa (onion)

Bismurrayafoline E

C48H56N2O4 (724.424)

Bismurrayafoline E is found in herbs and spices. Bismurrayafoline E is an alkaloid from the leaves of Murraya koenigii (curryleaf tree). Alkaloid from the leaves of Murraya koenigii (curryleaf tree). Bismurrayafoline E is found in herbs and spices.

PA(14:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C39H65O10P (724.4315)

PA(14:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(14:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)), in particular, consists of one chain of one tetradecanoyl at the C-1 position and one chain of Resolvin D5 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/14:0)

C39H65O10P (724.4315)

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/14:0), in particular, consists of one chain of one Resolvin D5 at the C-1 position and one chain of tetradecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C39H65O10P (724.4315)

PA(14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)), in particular, consists of one chain of one tetradecanoyl at the C-1 position and one chain of Protectin DX at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/14:0)

C39H65O10P (724.4315)

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/14:0), in particular, consists of one chain of one Protectin DX at the C-1 position and one chain of tetradecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(16:1(9Z)/PGJ2)

C39H65O10P (724.4315)

PA(16:1(9Z)/PGJ2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(16:1(9Z)/PGJ2), in particular, consists of one chain of one 9Z-hexadecenoyl at the C-1 position and one chain of Prostaglandin J2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGJ2/16:1(9Z))

C39H65O10P (724.4315)

PA(PGJ2/16:1(9Z)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGJ2/16:1(9Z)), in particular, consists of one chain of one Prostaglandin J2 at the C-1 position and one chain of 9Z-hexadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(i-14:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C39H65O10P (724.4315)

PA(i-14:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-14:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)), in particular, consists of one chain of one 12-methyltridecanoyl at the C-1 position and one chain of Resolvin D5 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-14:0)

C39H65O10P (724.4315)

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-14:0), in particular, consists of one chain of one Resolvin D5 at the C-1 position and one chain of 12-methyltridecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(i-14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C39H65O10P (724.4315)

PA(i-14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)), in particular, consists of one chain of one 12-methyltridecanoyl at the C-1 position and one chain of Protectin DX at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-14:0)

C39H65O10P (724.4315)

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-14:0), in particular, consists of one chain of one Protectin DX at the C-1 position and one chain of 12-methyltridecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Bismurrayafoline D

C48H56N2O4 (724.424)

Leupyrrin C

C40H56N2O10 (724.3935)

Archazolid B

C41H60N2O7S (724.4121)

unguisin B

C37H56N8O7 (724.4272)

subalpinoside

C37H56O14 (724.367)

ruscogenin 1-O-alpha-L-arabinopyranosyl-(1-2)-beta-D-glucopyranoside

C38H60O13 (724.4034)

(25R)-spirostan-3beta-ol-6-one-3-O-6)>-beta-D-glucopyranoside|laxogenin 3-O-6)-beta-D-glucopyranoside>|laxogenin 3-O-alpha-arabinopyranosyl(1->6)-beta-glucopyranoside|laxogenin 3-O-alpha-L-arabinopyranosyl-(1<*>6)-beta-D-glucopyranoside|laxogenin 3-O-alpha-L-arabinopyranosyl-(1[*]6)-beta-D-glucopyranoside|Laxogenin 3-O-[O-??-L-arabinopyranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside]|laxogenin-3-O-alpha-L-arabinopyranosyl-(1->6)-beta-D-glucopyranoside

C38H60O13 (724.4034)

25(S)-spirost-5-en-3beta,7alpha,27-triol 3-O-alpha-L-rhamnopyranosyl-(1->2)-beta-D-apiofuranoside|ypsilandroside C

C38H60O13 (724.4034)

25-O-Acetyldihdyrocucurbitacin F 2-O-beta-glucoside

C38H60O13 (724.4034)

Alliospiroside C

C38H60O13 (724.4034)

lushanrubescensin J

C40H52O12 (724.3459)

Roseolide A

C42H60O10 (724.4186)

C37H56O14

C37H56O14 (724.367)

C38H60O13

C38H60O13 (724.4034)

Swalpamycin

C37H56O14 (724.367)

C33H56O17

C33H56O17 (724.3517)

1-O-beta-D-xylopyranosyl-3-O-alpha-L-rhamnopyranosyl-(25S)-ruscogenin

C38H60O13 (724.4034)

(25R)-3beta-hydroxyspirost-5-en-1beta-yl O-alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinopyranoside

C38H60O13 (724.4034)

(25R)-5alpha-Spirostan-3beta-ol-6-one-3-O-4)>-beta-D-glucopyranoside|(25R)-5alpha-Spirostan-3beta-ol-6-one-3-O-[alpha-L-arabinopyranosyl(1->4)]-beta-D-glucopyranoside

C38H60O13 (724.4034)

tryptophyllin L3

C40H48N6O7 (724.3584)

SQD4

C38H60O13 (724.4034)

dimethyl 3-O-beta-D-glucopyranosylplatycogenate A

C38H60O13 (724.4034)

(25S)-Spirost-5-en-3beta,27-diol-3-O-6)>-beta-D-glucopyranoside|(25S)-Spirost-5-en-3beta,27-diol-3-O-[alpha-L-arabinopyranosyl(1->6)]-beta-D-glucopyranoside|(25S)-spirostan-5-en-3beta,27-diol 3-O-[alpha-L-arabinopyranosyl-(1?6)]-beta-D-glucopyranoside

C38H60O13 (724.4034)

acetylglucogitoroside|gitoxigenin 3-O-beta-D-glucopyranosyl-(1?4)-3-O-acetyl-beta-D-digitoxopyranoside

C37H56O14 (724.367)

bisjaponin A

C40H52O12 (724.3459)

2,2-Bi(1-hydroxy-3-methyl-4-(1,3-dimethyl-8-hydroxy-1,2,3,4-tetrahydroisoquinoline-7-yl)-8-methoxynaphthalene)

C46H48N2O6 (724.3512)

dixiamycin A|dixiamycin B

C46H48N2O6 (724.3512)

C46H48N2O6

C46H48N2O6 (724.3512)

(25R)-3?-hydroxy-5alpha-spirostan-6-one 3-O-alpha-L-arabinopyranosyl-(1?6)-?-D-glucopyranoside

C38H60O13 (724.4034)

cyclo-(L-Pro-L-Ser-DeltaZ-Trp-L-Leu-L-Val-Gly-L-Ser)|tunicyclin B

C36H52N8O8 (724.3908)

14-hydroxydiosgenin 3-O-beta-D-xylopyranosyl(1?4)-beta-D-glucopyranoside|ophiopogonin S

C38H60O13 (724.4034)

gymnemic acid X

C38H60O13 (724.4034)

(25R)-2alpha,3beta-dihydroxy-spirost-5-en-1beta-yl O-alpha-L-rhamnopyranosyl-(1->2)-beta-D-xylopyranoside|atropuroside A

C38H60O13 (724.4034)

(-)-Thalibealine

C42H48N2O9 (724.336)

Funkiosid c

C38H60O13 (724.4034)

25-O-acetyl-3-O-beta-D-glucopyranosyl-23,24-dihydrocucurbitacin F

C38H60O13 (724.4034)

filiasparoside B

C38H60O13 (724.4034)

dehydrohuangshanine

C42H48N2O9 (724.336)

Gymnemic aicd X

C38H60O13 (724.4034)

Met Glu Leu Tyr Arg

C32H52N8O9S (724.3578)

[(6R)-6-[(2S,3S,9R,13R,14S,16R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-11-oxo-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl] acetate

C38H60O13 (724.4034)

PI(12:0/14:1(9Z))

C35H65O13P (724.4163)

PI(14:1(9Z)/12:0)

C35H65O13P (724.4163)

Bismurrayafoline E

C48H56N2O4 (724.424)

PI 26:1

C35H65O13P (724.4163)

PKOOA-PI

C33H57O15P (724.3435)

O-TBDPS-D-Thr-N-Boc-L-tert-Leu-Diphenylphosphine

C43H57N2O4PSi (724.3825)

methyl (2Z)-2-[(1S,3S,7R,8E,11R,13E,15S,17R,21R,23R,25S)-1,11,21,25-tetrahydroxy-17-[(1R)-1-hydroxyethyl]-13-(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-5-ylidene]acetate

C37H56O14 (724.367)

PA(16:1(9Z)/PGJ2)

C39H65O10P (724.4315)

PA(PGJ2/16:1(9Z))

C39H65O10P (724.4315)

PA(14:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C39H65O10P (724.4315)

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/14:0)

C39H65O10P (724.4315)

PA(14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C39H65O10P (724.4315)

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/14:0)

C39H65O10P (724.4315)

PA(i-14:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C39H65O10P (724.4315)

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-14:0)

C39H65O10P (724.4315)

PA(i-14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C39H65O10P (724.4315)

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-14:0)

C39H65O10P (724.4315)

Archazolid F

C41H60N2O7S (724.4121)

A natural product found in Archangium gephyra.

Tunicyclin B

C35H48N8O9 (724.3544)

A natural product found in Psammosilene tunicoides.

6-de-O-acetylcupacinoside

C38H60O13 (724.4034)

A natural product found in Cupania cinerea.

(1S,2S,8xi,9beta,16alpha,17xi)-1-(beta-D-Glucopyranosyloxy)-2,16,20-trihydroxy-9,10,14-trimethyl-11,22-dioxo-4,9-cyclo-9,10-secocholest-5-en-25-yl acetate

C38H60O13 (724.4034)

CID 45783223

C38H60O13 (724.4034)

(1R,3S,9R,10S,13R,15E,17E,19E,21E,23R,25S,26R,27S)-23-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,9,27-tetrahydroxy-10,13-dimethyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxamide

C36H56N2O13 (724.3782)

[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] tetradecanoate

C35H64O15 (724.4245)

[1-Acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] octadecanoate

C35H64O15 (724.4245)

[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] pentadecanoate

C35H64O15 (724.4245)

[1-Nonanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] undecanoate

C35H64O15 (724.4245)

[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] heptadecanoate

C35H64O15 (724.4245)

[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] hexadecanoate

C35H64O15 (724.4245)

[1-Heptanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] tridecanoate

C35H64O15 (724.4245)

[1-Octanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] dodecanoate

C35H64O15 (724.4245)

[2-Decanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] decanoate

C35H64O15 (724.4245)

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C39H65O10P (724.4315)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-undecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C39H65O10P (724.4315)

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C39H65O10P (724.4315)

[1-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C39H65O10P (724.4315)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-octanoyloxypropan-2-yl] (Z)-octadec-9-enoate

C35H65O13P (724.4163)

[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-docos-13-enoate

C35H65O13P (724.4163)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-heptadec-9-enoate

C35H65O13P (724.4163)

[1-hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-icos-11-enoate

C35H65O13P (724.4163)

[1-heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-nonadec-9-enoate

C35H65O13P (724.4163)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-henicos-11-enoate

C35H65O13P (724.4163)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C39H65O10P (724.4315)

[1-dodecanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C35H65O13P (724.4163)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C39H65O10P (724.4315)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-pentadec-9-enoate

C35H65O13P (724.4163)

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropyl] (9Z,12Z)-heptadeca-9,12-dienoate

C39H65O10P (724.4315)

[3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] tridecanoate

C35H65O13P (724.4163)

[1-decanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C35H65O13P (724.4163)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C39H65O10P (724.4315)

[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-tetracos-13-enoate

C35H65O13P (724.4163)

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoate

C42H61O8P (724.4104)

[(2R)-1-decanoyloxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] (E)-hexadec-7-enoate

C35H65O13P (724.4163)

[(2S,3S,6S)-6-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H56O12S (724.3492)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C39H65O10P (724.4315)

[(2R)-2-decanoyloxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (E)-hexadec-9-enoate

C35H65O13P (724.4163)

[(2S)-2-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-[[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] decanoate

C35H64O15 (724.4245)

[(2R)-2-decanoyloxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (E)-hexadec-7-enoate

C35H65O13P (724.4163)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C39H65O10P (724.4315)

[(2R)-1-dodecanoyloxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] (E)-tetradec-9-enoate

C35H65O13P (724.4163)

[3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropyl] (8E,11E,14E)-heptadeca-8,11,14-trienoate

C39H65O10P (724.4315)

[(2R)-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-2-undecanoyloxypropyl] (E)-pentadec-9-enoate

C35H65O13P (724.4163)

[(2R)-1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-pentadec-9-enoate

C35H65O13P (724.4163)

[(2S,3S,6S)-6-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H56O12S (724.3492)

[(2R)-2-dodecanoyloxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (E)-tetradec-9-enoate

C35H65O13P (724.4163)

[(2R)-1-decanoyloxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] (E)-hexadec-9-enoate

C35H65O13P (724.4163)

[3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] (11E,14E)-heptadeca-11,14-dienoate

C39H65O10P (724.4315)

[3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] (E)-heptadec-7-enoate

C39H65O10P (724.4315)

(15E,17E,19E,21E)-23-(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy-1,3,9,27-tetrahydroxy-10,13-dimethyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxamide

C36H56N2O13 (724.3782)

1-dodecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phospho-(1-myo-inositol)

C35H65O13P (724.4163)

1-decanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-(1-myo-inositol)

C35H65O13P (724.4163)

phosphatidylserine 32:5(1-)

C38H63NO10P (724.4189)

A 3-sn-phosphatidyl-L-serine(1-) in which the acyl groups at C-1 and C-2 contain 32 carbons in total and 5 double bonds.

DGDG 10:0_10:0

C35H64O15 (724.4245)

DGDG 20:0

C35H64O15 (724.4245)

DGDG O-20:1;O

C35H64O15 (724.4245)

SMGDG O-26:2;O

C35H64O13S (724.4067)

SMGDG O-28:8

C37H56O12S (724.3492)

SQDG 26:1;O

C35H64O13S (724.4067)

SQDG 28:7

C37H56O12S (724.3492)

SQMG 29:7

C38H60O11S (724.3856)

PA O-36:7;O3

C39H65O10P (724.4315)

PA P-16:1/20:5;O3

C39H65O10P (724.4315)

PA 14:0/22:6;O2

C39H65O10P (724.4315)

PA 14:1/22:5;O2

C39H65O10P (724.4315)

PA 16:0/20:6;O2

C39H65O10P (724.4315)

PA 16:1/20:5;O2

C39H65O10P (724.4315)

PA 18:4/18:2;O2

C39H65O10P (724.4315)

PA 36:6;O2

C39H65O10P (724.4315)

BMP 33:6

C39H65O10P (724.4315)

HBMP 31:7;O

C37H57O12P (724.3587)

HBMP 32:6

C38H61O11P (724.3951)

PG 18:4/13:4;O2

C37H57O12P (724.3587)

PG 20:4/12:3;O

C38H61O11P (724.3951)

PG 22:0/7:2;O3

C35H65O13P (724.4163)

PG 22:4/9:4;O2

C37H57O12P (724.3587)

PG 29:2;O3

C35H65O13P (724.4163)

PG 31:8;O2

C37H57O12P (724.3587)

PG 32:7;O

C38H61O11P (724.3951)

PG 11:0_22:6

C39H65O10P (724.4315)

PG 33:6

C39H65O10P (724.4315)

PI O-18:0/7:3;O2

C34H61O14P (724.3799)

PI O-20:0/6:2;O

C35H65O13P (724.4163)

PI O-24:4;O3

C33H57O15P (724.3435)

PI O-25:3;O2

C34H61O14P (724.3799)

PI O-26:2;O

C35H65O13P (724.4163)

PI P-16:0/8:3;O3

C33H57O15P (724.3435)

PI P-16:1/8:2;O3

C33H57O15P (724.3435)

PI P-16:1/9:1;O2

C34H61O14P (724.3799)

PI P-18:0/7:2;O2

C34H61O14P (724.3799)

PI P-18:0/8:1;O

C35H65O13P (724.4163)

PI P-20:1/5:1;O2

C34H61O14P (724.3799)

PI 14:0/11:2;O

C34H61O14P (724.3799)

PI 16:0/8:3;O2

C33H57O15P (724.3435)

PI 16:1/8:2;O2

C33H57O15P (724.3435)

PI 16:1/9:1;O

C34H61O14P (724.3799)

PI 20:1/5:1;O

C34H61O14P (724.3799)

PI 20:2/4:1;O2

C33H57O15P (724.3435)

PI 25:2;O

C34H61O14P (724.3799)

PI 10:0_16:1

C35H65O13P (724.4163)

PI 11:0_15:1

C35H65O13P (724.4163)

PI 12:0_14:1

C35H65O13P (724.4163)

PI 22:0/4:1

C35H65O13P (724.4163)

PI 22:1/4:0

C35H65O13P (724.4163)

PI 24:1/2:0

C35H65O13P (724.4163)

(2s,3r,4r,5r,6s)-2-{[(2s,3r,4r)-4-hydroxy-4-(hydroxymethyl)-2-[(1'r,2r,2's,4's,5s,7's,8's,9's,12's,13'r,16's)-5-(hydroxymethyl)-7',9',13'-trimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-8'-oloxy]oxolan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C38H60O13 (724.4034)

8,8'-bis(3,7-dimethylocta-2,6-dien-1-yl)-7,7'-dimethoxy-3,3'-dimethyl-9h,9'h-[2,2'-bicarbazole]-1,1'-diol

C48H56N2O4 (724.424)

8,8'-bis[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-7,7'-dimethoxy-3,3'-dimethyl-9h,9'h-[1,1'-bicarbazole]-2,2'-diol

C48H56N2O4 (724.424)

(3s,4s,4ar,13bs)-8-[(3s,4s,4ar,13bs)-4-carboxy-3-hydroxy-4,13b-dimethyl-1h,2h,3h,4ah,5h,6h-naphtho[2,1-b]carbazol-8-yl]-3-hydroxy-4,13b-dimethyl-1h,2h,3h,4ah,5h,6h-naphtho[2,1-b]carbazole-4-carboxylic acid

C46H48N2O6 (724.3512)

4,8a-dimethyl (2s,3r,4s,4ar,6ar,6bs,8r,8ar,12as,14ar,14br)-2,8-dihydroxy-4-(hydroxymethyl)-6a,6b,11,11,14b-pentamethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylate

C38H60O13 (724.4034)

n-methyl(1-{4-[(4e,6e,11e,19e,22e)-10,18-dihydroxy-8-methoxy-3,7,9,13,15,17,20-heptamethyl-24-oxo-1-oxacyclotetracosa-4,6,11,13,15,19,22-heptaen-2-yl]-1,3-thiazol-2-yl}-3-methylbutoxy)carboximidic acid

C41H60N2O7S (724.4121)

(6r)-6-[(1r,2r,3as,3br,7s,8s,9ar,9br,11ar)-2,7-dihydroxy-3a,6,6,9b,11a-pentamethyl-10-oxo-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl acetate

C38H60O13 (724.4034)

(3s,4s,4ar,13bs)-8-[(3s,4s,4ar,13bs)-4-carboxy-3-hydroxy-4,13b-dimethyl-1h,2h,3h,4ah,5h,6h,8h-naphtho[2,1-b]carbazol-7-yl]-3-hydroxy-4,13b-dimethyl-1h,2h,3h,4ah,5h,6h-naphtho[2,1-b]carbazole-4-carboxylic acid

C46H48N2O6 (724.3512)

(1r,3s,9r,10s,13r,15e,17e,19e,21e,23r,25s,26r,27s)-23-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,9,27-tetrahydroxy-10,13-dimethyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboximidic acid

C36H56N2O13 (724.3782)

8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-8'-[(2z)-3,7-dimethylocta-2,6-dien-1-yl]-7,7'-dimethoxy-3,3'-dimethyl-9h,9'h-[2,2'-bicarbazole]-1,1'-diol

C48H56N2O4 (724.424)

(3r,6r,9s,12r,15r)-3-(1h-indol-3-ylmethyl)-6,9,12-triisopropyl-15-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclodocosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17,20-heptol

C37H56N8O7 (724.4272)

n-methyl{1-[4-(10,18-dihydroxy-8-methoxy-3,7,9,13,15,17,20-heptamethyl-24-oxo-1-oxacyclotetracosa-4,6,11,13,15,19,22-heptaen-2-yl)-1,3-thiazol-2-yl]-3-methylbutoxy}carboximidic acid

C41H60N2O7S (724.4121)

(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's,18's)-5,7',9',13'-tetramethyl-16'-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-19'-one

C38H60O13 (724.4034)

(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's,18's)-16'-{[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-19'-one

C38H60O13 (724.4034)

(1r,2s,3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(2r,4s,5s,6r)-4-hydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C37H56O14 (724.367)

(7r,9r)-9-({4,5-dihydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-7-hydroxy-1-[(2s,6r)-7-hydroxy-6-methyl-3-oxoheptan-2-yl]-9a,11a-dimethyl-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one

C38H60O13 (724.4034)

(2s,3r,4r,5r,6s)-2-{[(2s,3r,4s,5s)-4,5-dihydroxy-2-[(1's,2r,2's,4s,4's,5r,7's,8'r,9's,12's,13'r,14'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-4,14'-dioloxy]oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C38H60O13 (724.4034)

(7e)-12-(hydroxymethyl)-22-{[(3z,4z)-4-(5-hydroxypentan-2-ylidene)-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7-tetraene-11,15,18-trione

C40H56N2O10 (724.3935)

methyl (1r,2r,3s,8r,10s,13e,17z,21s,22s,23z,27s,28r)-3-(acetyloxy)-2,28-dihydroxy-10-isopropyl-6,13,17,24,28-pentamethyl-9,12,19-trioxo-31-oxatetracyclo[25.3.1.0⁵,²².0⁸,²¹]hentriaconta-5,13,17,23-tetraene-21-carboxylate

C42H60O10 (724.4186)

1,2,3,10,11-pentamethoxy-4-({3,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-6-yl}oxy)-7,8,12b,13-tetrahydro-5h-6-azatetraphene

C42H48N2O9 (724.336)

12-(hydroxymethyl)-22-{[4-(5-hydroxypentan-2-ylidene)-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7-tetraene-11,15,18-trione

C40H56N2O10 (724.3935)

15-{[(5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl)oxy]methyl}-6-({6-hydroxy-4,9-dimethyl-2-oxo-1,3,8-trioxaspiro[4.5]decan-7-yl}oxy)-5,7,9,16-tetramethyl-1-oxacyclohexadeca-3,11,13-triene-2,10-dione

C37H56O14 (724.367)

5,7',9',13'-tetramethyl-16'-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-19'-one

C38H60O13 (724.4034)

(12br)-2,3,10,11-tetramethoxy-1-{[(9s)-4,14,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-yl]oxy}-7,8,12b,13-tetrahydro-5h-6-azatetraphene

C42H48N2O9 (724.336)

(2s,3s,4s,5s)-2-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,14'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy]oxan-3-yl]oxy}oxane-3,4,5-triol

C38H60O13 (724.4034)

(2s)-2-{[(2r)-2-({[(2r)-1-[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-(1h-indol-3-yl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxy-4-methylpentylidene]amino}-3-phenylpropanoic acid

C40H48N6O7 (724.3584)

(2s,3r,4r,5r,6s)-2-{[(2s,3r,4s,5r)-4,5-dihydroxy-2-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,14's,15's,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-15',16'-dioloxy]oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C38H60O13 (724.4034)

5,7',9',13'-tetramethyl-16'-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one

C38H60O13 (724.4034)

(1r,4r,7s,8r,9s)-1-{[(1e,3s,4r,9s,10r,11s,14r)-9,14-dihydroxy-6-isopropyl-14-(methoxymethyl)-3,10-dimethyl-5-oxotricyclo[9.3.0.0³,⁷]tetradeca-1,6-dien-4-yl]methyl}-4,9-dihydroxy-12-isopropyl-4-(methoxymethyl)-8-methyl-14-oxatricyclo[9.4.0.0³,⁷]pentadeca-2,11-diene-13,15-dione

C42H60O10 (724.4186)

2-[(4,5-dihydroxy-2-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-15',16'-dioloxy}oxan-3-yl)oxy]-6-methyloxane-3,4,5-triol

C38H60O13 (724.4034)

(1r,2s,3as,5ar,7s,9as,11ar)-3a-hydroxy-7-[(4-hydroxy-6-methyl-5-{[(2s,3s,5s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate

C37H56O14 (724.367)

6-(2,7-dihydroxy-3a,6,6,9b,11a-pentamethyl-10-oxo-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl)-6-hydroxy-2-methyl-5-oxoheptan-2-yl acetate

C38H60O13 (724.4034)

2-[(4,5-dihydroxy-2-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-4,14'-dioloxy}oxan-3-yl)oxy]-6-methyloxane-3,4,5-triol

C38H60O13 (724.4034)

(2s,3r,4r,5r,6s)-2-{[(2s,3r,4s,5r)-4,5-dihydroxy-2-[(1's,2r,2's,4s,4's,5s,7's,8'r,9's,12's,13'r,14'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-4,16'-dioloxy]oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C38H60O13 (724.4034)

n-methyl{1-[4-(10,18-dihydroxy-8-methoxy-3,7,9,13,15,17,20-heptamethyl-24-oxo-1-oxacyclotetracosa-4,6,11,13,15,19,21-heptaen-2-yl)-1,3-thiazol-2-yl]-3-methylbutoxy}carboximidic acid

C41H60N2O7S (724.4121)

2-{[2-({[1-(2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-(1h-indol-3-yl)propanoyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxy-4-methylpentylidene]amino}-3-phenylpropanoic acid

C40H48N6O7 (724.3584)

(3z,11z,13z)-15-({[(2r,3r,4r,5r,6r)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxy}methyl)-6-{[(4s,5r,6r,7s,9r)-6-hydroxy-4,9-dimethyl-2-oxo-1,3,8-trioxaspiro[4.5]decan-7-yl]oxy}-5,7,9,16-tetramethyl-1-oxacyclohexadeca-3,11,13-triene-2,10-dione

C37H56O14 (724.367)

n-methyl[(1s)-1-{4-[(2s,3s,4e,6e,8s,9s,10r,11e,13z,15z,17s,18s,19e,21e)-10,18-dihydroxy-8-methoxy-3,7,9,13,15,17,20-heptamethyl-24-oxo-1-oxacyclotetracosa-4,6,11,13,15,19,21-heptaen-2-yl]-1,3-thiazol-2-yl}-3-methylbutoxy]carboximidic acid

C41H60N2O7S (724.4121)

2-{[4,5-dihydroxy-6-(hydroxymethyl)-2-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy}oxan-3-yl]oxy}oxane-3,4,5-triol

C38H60O13 (724.4034)

4,8a-dimethyl 2,8-dihydroxy-4-(hydroxymethyl)-6a,6b,11,11,14b-pentamethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylate

C38H60O13 (724.4034)

(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13's,16's,18's)-5,7',9',13'-tetramethyl-16'-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one

C38H60O13 (724.4034)

4-{2,5-dimethyl-13-azaoctacyclo[14.6.1.1¹⁴,¹⁸.0²,¹⁰.0⁴,¹⁰.0⁵,⁹.0⁸,¹³.0¹⁷,²¹]tetracosa-1(23),14(24),15,17,19,21-hexaen-4-ylsulfinyl}-2,5-dimethyl-13-azaoctacyclo[14.6.1.1¹⁴,¹⁸.0²,¹⁰.0⁴,¹⁰.0⁵,⁹.0⁸,¹³.0¹⁷,²¹]tetracosa-1(22),14,16(23),17(21),18(24),19-hexaene

C50H48N2OS (724.3487)

2-methyl 4a-(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2s,4ar,6as,6br,8ar,9r,10r,11s,12as,12br,13r,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-13-methoxy-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2,4a-dicarboxylate

C38H60O13 (724.4034)

(2s,3s,4r,5r,6s)-6-({[(3s,4r,4ar,6ar,6bs,8s,8ar,9r,10r,12as,14as,14br)-8a-[(acetyloxy)methyl]-8,9,10-trihydroxy-4-(hydroxymethyl)-4,6a,11,11,14b-pentamethyl-2,3,4a,5,6,6b,7,8,9,10,12,12a,14,14a-tetradecahydro-1h-picen-3-yl]oxy}methyl)-3,4,5-trihydroxyoxane-2-carboxylic acid

C38H60O13 (724.4034)

8,8'-bis(3,7-dimethylocta-2,6-dien-1-yl)-7,7'-dimethoxy-3,3'-dimethyl-9h,9'h-[1,1'-bicarbazole]-2,2'-diol

C48H56N2O4 (724.424)

2-[5-(hydroxymethyl)-7',9',13'-trimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxane-3,4,5-triol

C38H60O13 (724.4034)

(1s,5r,9r,12s,16r,17s,21r,25r,28s,32r)-1,5,17,21-tetramethyl-13,29-dimethylidene-9,25-bis[(3s)-2-oxooxolan-3-yl]-7,10,23,26-tetraoxapentacyclo[26.4.0.0⁵,³².0¹²,¹⁷.0¹⁶,²¹]dotriacontane-8,24-dione

C42H60O10 (724.4186)

(3r,6r,9r,12s,15r,18r)-12-[(2r)-butan-2-yl]-3-(1h-indol-3-ylmethyl)-9,15-diisopropyl-6,18-dimethyl-1,4,7,10,13,16,19-heptaazacyclotricosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17,20-heptol

C37H56N8O7 (724.4272)

6-[({8a-[(acetyloxy)methyl]-8,9,10-trihydroxy-4-(hydroxymethyl)-4,6a,11,11,14b-pentamethyl-2,3,4a,5,6,6b,7,8,9,10,12,12a,14,14a-tetradecahydro-1h-picen-3-yl}oxy)methyl]-3,4,5-trihydroxyoxane-2-carboxylic acid

C38H60O13 (724.4034)

2-{[4-hydroxy-4-(hydroxymethyl)-2-[5-(hydroxymethyl)-7',9',13'-trimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-8'-oloxy]oxolan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C38H60O13 (724.4034)

8,8'-bis[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-7,7'-dimethoxy-3,3'-dimethyl-9h,9'h-[2,2'-bicarbazole]-1,1'-diol

C48H56N2O4 (724.424)

(12br)-2,3,10,11-tetramethoxy-1-{[(9r)-4,14,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-yl]oxy}-7,8,12b,13-tetrahydro-5h-6-azatetraphene

C42H48N2O9 (724.336)

(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's,18's)-5,7',9',13'-tetramethyl-16'-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-({[(2r,3s,4r,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-19'-one

C38H60O13 (724.4034)

(2r,3r,4s,5s,6r)-2-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16's)-5-(hydroxymethyl)-7',9',13'-trimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-eneoxy]-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C38H60O13 (724.4034)

n-methyl[(1s)-1-{4-[(2r,3r,4z,6z,8r,9r,10r,11e,13e,15z,17s,18r,19e,22e)-10,18-dihydroxy-8-methoxy-3,7,9,13,15,17,20-heptamethyl-24-oxo-1-oxacyclotetracosa-4,6,11,13,15,19,22-heptaen-2-yl]-1,3-thiazol-2-yl}-3-methylbutoxy]carboximidic acid

C41H60N2O7S (724.4121)

(7e,9r,12r,13s,17s,21s,22s)-12-(hydroxymethyl)-22-{[(2s,3z,4z)-4-(5-hydroxypentan-2-ylidene)-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7-tetraene-11,15,18-trione

C40H56N2O10 (724.3935)

(2s,3r,4r,5r,6s)-2-methyl-6-{[(2r,3r,4s,5r,6s)-4,5,6-trihydroxy-2-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,14'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy]oxan-3-yl]oxy}oxane-3,4,5-triol

C38H60O13 (724.4034)

(3s,4s,4ar,13bs)-11-[(3s,4s,4ar,13bs)-4-carboxy-3-hydroxy-4,13b-dimethyl-1h,2h,3h,4ah,5h,6h-naphtho[2,1-b]carbazol-8-yl]-3-hydroxy-4,13b-dimethyl-1h,2h,3h,4ah,5h,6h,8h-naphtho[2,1-b]carbazole-4-carboxylic acid

C46H48N2O6 (724.3512)

(2s,3r,4r,5r,6s)-2-{[(2s,3r,4s,5s)-4,5-dihydroxy-2-[(1's,2r,2's,4s,4's,5s,7's,8'r,9's,12's,13'r,14'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-4,16'-dioloxy]oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C38H60O13 (724.4034)

16'-{[3,4-dihydroxy-6-(hydroxymethyl)-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-19'-one

C38H60O13 (724.4034)

n-methyl[(1s)-1-{4-[(2r,3r,4e,6e,8r,9r,10r,11e,13z,15z,17s,18r,19e,22e)-10,18-dihydroxy-8-methoxy-3,7,9,13,15,17,20-heptamethyl-24-oxo-1-oxacyclotetracosa-4,6,11,13,15,19,22-heptaen-2-yl]-1,3-thiazol-2-yl}-3-methylbutoxy]carboximidic acid

C41H60N2O7S (724.4121)

3-(1h-indol-3-ylmethyl)-9,15-diisopropyl-6,18-dimethyl-12-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclotricosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17,20-heptol

C37H56N8O7 (724.4272)

6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy}-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxane-2,3,4-triol

C38H60O13 (724.4034)

2,3,10,11-tetramethoxy-1-({4,14,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-yl}oxy)-7,8,12b,13-tetrahydro-5h-6-azatetraphene

C42H48N2O9 (724.336)

(7e,9s,12s,13s,17s,21r,22s)-12-(hydroxymethyl)-22-{[(2r,3z,4z)-4-(5-hydroxypentan-2-ylidene)-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7-tetraene-11,15,18-trione

C40H56N2O10 (724.3935)

(3r,6r,9r,12s,15r,18r)-3-(1h-indol-3-ylmethyl)-9,15-diisopropyl-6,18-dimethyl-12-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclotricosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17,20-heptol

C37H56N8O7 (724.4272)

2-[(4,5-dihydroxy-2-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-4,16'-dioloxy}oxan-3-yl)oxy]-6-methyloxane-3,4,5-triol

C38H60O13 (724.4034)

(7e,17s)-12-(hydroxymethyl)-22-{[(3z,4z)-4-(5-hydroxypentan-2-ylidene)-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7-tetraene-11,15,18-trione

C40H56N2O10 (724.3935)